Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Zhejiang Key Laboratory of Minimally Invasive Technique and Precision Medicine, Zhejiang University, Hangzhou 310016, China
Auto-generated profile, based on publicly available information
Dong Cen
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Zhejiang Key Laboratory of Minimally Invasive Technique and Precision Medicine, Zhejiang University, Hangzhou 310016, China
Emerging evidence has shown that open reading frames inside long noncoding RNAs (lncRNAs) could encode micropeptides. However, their roles in cellular energy metabolism and tumor progression remain largely unknown. Here, we identified a 94 amino acid–length micropeptide encoded by lncRNA LINC00467 in colorectal cancer. We also characterized its conservation across higher mammals, localization to mitochondria, and the concerted local functions. This peptide enhanced the ATP synthase construction by interacting with the subunits α and γ (ATP5A and ATP5C), increased ATP synthase activity and mitochondrial oxygen consumption rate, and thereby promoted colorectal cancer cell proliferation. Hence, this micropeptide was termed ATP synthase–associated peptide (ASAP). Furthermore, loss of ASAP suppressed patient-derived xenograft growth with attenuated ATP synthase activity and mitochondrial ATP production. Clinically, high expression of ASAP and LINC00467 predicted poor prognosis of colorectal cancer patients. Taken together, our findings revealed a colorectal cancer–associated micropeptide as a vital player in mitochondrial metabolism and provided a therapeutic target for colorectal cancer.
Severe acute pancreatitis (SAP) is a life-threatening condition characterized by excessive reactive oxygen species (ROS) production and impaired mitochondrial function, resulting from disrupted autophagic flux. Current clinical treatment for SAP fails to address the condition comprehensively, with the treatment targeting only a single pathogenesis. Herein, we report an innovative acid-responsive biomimetic nanozyme. This system features a hollow Prussian blue (PB) core, serving as an ROS scavenger encapsulated within a porous ZIF-8 shell, enabling the efficient delivery of celastrol that activates autophagic flux. Encased in a macrophage membrane, this system selectively targets inflamed pancreatic tissues and is readily internalized by pancreatic acinar cells. This dual-scavenging mechanism effectively attenuates inflammatory cytokine levels and restores mitochondrial homeostasis in three distinct SAP mouse models. Overall, this study presents a promising synergistic strategy for the dual scavenging of damaged mitochondria and ROS, offering a novel therapeutic approach to the treatment of SAP.
Pro‐inflammatory photodynamic therapy (PDT) holds immense potential to ignite robust and long‐lasting systemic anti‐tumor immune responses. However, the limited penetration depth of conventional ultra violet (UV)‐visible irradiation and the tumor hypoxia microenvironment significantly constrain the efficacy of immune‐regulatory PDT. Here, a mitochondria‐targeting enhanced nanoplatform (NZ @TG ) is reported, activated by near‐infrared (NIR) light‐driven PDT, to address these challenges and amplify systemic anti‐tumor immunity. This nanoplatform employs an interfacial lanthanide‐organic triplet photosensation mechanism to realize localized oxidative damage of oxygen‐rich mitochondria under NIR irradiation. Simultaneously, the exacerbated hypoxia induced by PDT activates a TH302 prodrug, resulting in cell cycle arrest in highly proliferative tumor cells. These combined effects trigger immunogenic cell death (ICD), releasing damage‐associated molecular patterns (DAMPs) to activate immune responses. This approach demonstrates significantly enhanced tumor ablation in deep‐seated lesions in orthotopic liver tumor models and induces long‐term anti‐tumor immune memory. Moreover, the NIR‐PDT‐induced immune activation markedly improves the immune checkpoint blockade (ICB) therapy efficacy. This strategy offers a robust modality for immune activation in cancer therapy, paving the way for effective treatment of deep‐seated tumors and preventing recurrence.
Nanozyme is a new promising approach to cancer therapy for its ability to induce ferroptosis by activating H2O2 via a traditional radical pathway and enhance cancer immunotherapy. However, short half-life period of hydroxyl radical (·OH) results in unsatisfied effectiveness. Herein, we synthesized a single-atom iron nanozyme (Fe-SAzyme), which can activate H2O2 via a non-radical pathway to generate Fe-based reactive oxygen species (ROS) (O=FeO3=O) for promoting the ferroptosis of pancreatic cancer cells. This Fe-SAzyme could be specifically phagocytosed by pancreatic cancer cells, increasing ROS levels and inhibiting glutathione (GSH) synthesis, which activates ferroptosis. Tumor magnetic resonance imaging (MRI) showed decreased T2 signal after intravenous injection of RGD@Fe-AC (AC = activated carbon). Moreover, RGD@Fe-AC promoted dendritic cell (DC) maturation, overcame Treg-mediated immunosuppression, activated T cells to trigger adaptive immune responses, and enhanced the efficacy of α-PD-L1 immunotherapy. Our research demonstrated that RGD@Fe-AC provided a straightforward, easily implemented, and selective approach for pancreatic cancer treatment and immunotherapy.
12 August 2022 in Canadian Journal of Gastroenterology and Hepatology
Delta-shaped gastroduodenostomy (DSGD) and overlap gastroduodenostomy (OGD) are the two most widely used intracorporeal Billroth I anastomosis methods after distal gastrectomy. In this study, we compared the short-term outcomes of DSGD and OGD in total laparoscopic distal gastrectomy (TLDG). In a retrospective cohort study, we examined 92 gastric cancer patients who underwent TLDG performed by the same surgeon between January 2014 and June 2018. All patients underwent Billroth I reconstruction (OGD, n = 45; DSGD, n = 47) and D2 lymph node dissection. We retrospectively reviewed the surgical outcomes, clinical pathological results, and endoscopy results. Laparoscopic surgery was successfully performed in both groups without conversion to open surgery. The demographic and clinical characteristics were similar between the two groups ( ). There were no significant differences between the two groups in operation time (158.9 ± 13.6 min vs. 158.8 ± 14.8 min, ), anastomotic time (19.4 ± 3.0 min vs. 18.8 ± 2.9 min, ), intraoperative blood loss (88.9 ± 25.4 mL vs. 83.7 ± 24.3 mL, ), number of lymph node dissections (31.0 ± 7.1 vs. 29.2 ± 7.5, ), length of hospital stay (8.8 ± 2.7 days vs. 9.1 ± 3.0 days, ), fluid intake time (3.1 ± 0.7 days vs. 3.2 ± 0.7 days, ), and morbidity of postoperative complications (6.7% [3/45] vs. 10.6% [5/47], ). Endoscopy performed 6 months postoperatively showed that the residual food ( ), gastritis ( ), and bile ( ) classification score significantly decreased in the OGD group, and there were no significant differences 12 months postoperatively. OGD is a safe and effective reconstruction technique with comparable postoperative surgical outcomes and endoscopy results when compared with those of DSGD.
Glucose oxidase (GOx)-based starvation therapy has emerged as a promising strategy in tumor therapy. However, the non-specific catalytic activity and premature degradation of GOx during systemic circulation have limited its therapeutic efficacy in tumor regions. In this study, we present the synthesis of ultrasound/glutathione dual-responsive ZIF-8-GOx@copper-polydopamine@liposome-L-arginine (ZGCLL) nanoparticles, designed to concurrently achieve ion interference therapy, starvation therapy, and ultrasound-catalyzed gas therapy. The ZIF-8-GOx nanoparticles are prepared via a co-precipitation method, followed by the encapsulation of a copper-polydopamine (Cu-PDA) shell on the particle surface. Subsequently, liposomes and L-arginine are incorporated to form ZGCLL. The Cu-PDA shell exhibits responsiveness to the elevated level of glutathione in tumor microenvironment, leading to its degradation, mitigating the risk of unintended degradation and 'off-target' effect of GOx in normal tissues. The exposure of ZIF-8 results in zinc overload and activates the catalytic reaction of GOx. The consequent depletion of glucose facilitates starvation therapy, while the generated H2O2, in synergy with zinc ions, intensifies oxidative stress. H2O2 can produce more potent reactive oxygen species when exposed to ultrasound, which subsequently react with L-arginine to generate higher levels of nitric oxide for gas therapy. Both in vitro and in vivo studies demonstrate that this platform achieves precise and efficient antitumor effects. This research offers an innovative strategy for the development of cascade catalytic reaction systems and targeted therapeutic platforms.